Find a Product

Webinar: A Phenotypic Platform for Characterization of Drug Safety Mechanisms in Human Primary Cell Disease Models


Wednesday, May 25, 2016

Watch Now

What if there was a way to inform the safety of a drug candidate that was more clinically relevant than animal models and better correlated with clinical outcomes?

Watch this webinar to learn about a human primary cell-based system that compares your drug compounds to the toxicity profiles of over 4,000 reference compounds. See how you can achieve data that associates risk of acute and organ-specific adverse events of the skin, immune system, vasculature, and liver.

What will be covered?

  • How to maximize knowledge of your compounds using the BioMAP® Diversity PLUS™ panel of human primary cells systems
  • How to understand mechanism classification analysis and toxicity signatures
  • A case study on discovery of a mechanism-based novel signature for skin irritation

Who should attend?

  • Scientists with a compound in preclinical development
  • Toxicity and saftey groups
  • Researchers with an interest in toxicity prediction